192 related articles for article (PubMed ID: 29604391)
1. Macular corneal dystrophy: A review.
Aggarwal S; Peck T; Golen J; Karcioglu ZA
Surv Ophthalmol; 2018; 63(5):609-617. PubMed ID: 29604391
[TBL] [Abstract][Full Text] [Related]
2. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty.
Küchle M; Cursiefen C; Fischer DC; Schlötzer-Schrehardt U; Naumann GO
Arch Ophthalmol; 1999 Apr; 117(4):528-31. PubMed ID: 10206585
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
[TBL] [Abstract][Full Text] [Related]
4. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.
Hassell JR; Newsome DA; Krachmer JH; Rodrigues MM
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3705-9. PubMed ID: 6447876
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of proteoglycans and glycoproteins synthesized by corneal organ cultures derived from patients with macular corneal dystrophy.
Klintworth GK; Smith CF
Lab Invest; 1983 May; 48(5):603-12. PubMed ID: 6601743
[TBL] [Abstract][Full Text] [Related]
6. Macular Corneal Dystrophy: An Updated Review.
Singh S; Das S; Kannabiran C; Jakati S; Chaurasia S
Curr Eye Res; 2021 Jun; 46(6):765-770. PubMed ID: 33171054
[TBL] [Abstract][Full Text] [Related]
7. Corneal dystrophies.
Bourges JL
J Fr Ophtalmol; 2017 Jun; 40(6):e177-e192. PubMed ID: 28583694
[TBL] [Abstract][Full Text] [Related]
8. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA
Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226
[TBL] [Abstract][Full Text] [Related]
9. Primary graft failure after big bubble deep anterior lamellar keratoplasty in macular corneal dystrophy.
Chaurasia S; Ramappa M; Murthy S; Garg P
Indian J Ophthalmol; 2018 Aug; 66(8):1196-1197. PubMed ID: 30038180
[TBL] [Abstract][Full Text] [Related]
10. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
[TBL] [Abstract][Full Text] [Related]
11. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
12. Defective processing of keratan sulfate in macular corneal dystrophy.
Nakazawa K; Hassell JR; Hascall VC; Lohmander LS; Newsome DA; Krachmer J
J Biol Chem; 1984 Nov; 259(22):13751-7. PubMed ID: 6238957
[TBL] [Abstract][Full Text] [Related]
13. Macular Corneal Dystrophy in an Adolescent Managed with Deep Anterior Lamellar Keratoplasty.
Giri P; Bajracharya L; Ranabhat S
Nepal J Ophthalmol; 2022 Jan; 14(27):204-209. PubMed ID: 35996921
[TBL] [Abstract][Full Text] [Related]
14. [Granular corneal dystrophy treated with deep anterior lamellar keratoplasty: comparing histological analysis and optical coherence tomography].
Combillet F; Touboul D; Leger F; Colin J
J Fr Ophtalmol; 2012 Jan; 35(1):50.e1-5. PubMed ID: 21680057
[TBL] [Abstract][Full Text] [Related]
15. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing.
Quantock AJ; Meek KM; Ridgway AE; Bron AJ; Thonar EJ
Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750
[TBL] [Abstract][Full Text] [Related]
16. Serum sulfotransferase levels in patients with macular corneal dystrophy type I.
Hassell JR; Klintworth GK
Arch Ophthalmol; 1997 Nov; 115(11):1419-21. PubMed ID: 9366673
[TBL] [Abstract][Full Text] [Related]
17. Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea.
Di Iorio E; Barbaro V; Volpi N; Bertolin M; Ferrari B; Fasolo A; Arnaldi R; Brusini P; Prosdocimo G; Ponzin D; Ferrari S
Exp Eye Res; 2010 Aug; 91(2):293-9. PubMed ID: 20537995
[TBL] [Abstract][Full Text] [Related]
18. Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducing end N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: comparison between normal controls and patients with macular corneal dystrophy.
Hasegawa N; Torii T; Nagaoka I; Nakayasu K; Miyajima H; Habuchi O
J Biochem; 1999 Feb; 125(2):245-52. PubMed ID: 9990120
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Wilkins S; Cheetham ME; Wilkie SE; Hardcastle AJ; Halford S; Bayoumi AY; Ficker LA; Tuft S; Bhattacharya SS; Ebenezer ND
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):377-82. PubMed ID: 11818380
[TBL] [Abstract][Full Text] [Related]
20. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy.
Thonar EJ; Meyer RF; Dennis RF; Lenz ME; Maldonado B; Hassell JR; Hewitt AT; Stark WJ; Stock EL; Kuettner KE
Am J Ophthalmol; 1986 Nov; 102(5):561-9. PubMed ID: 2946233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
